Leptin is a potential biomarker of childhood obesity and an indicator of the effectiveness of weight-loss interventions

Obes Rev. 2024 Nov;25(11):e13807. doi: 10.1111/obr.13807. Epub 2024 Jul 23.

Abstract

Childhood obesity represents a significant public health concern, imposing a substantial burden on the healthcare system. Furthermore, weight-loss programs often exhibit reduced effectiveness in adults who have a history of childhood obesity. Therefore, early intervention against childhood obesity is imperative. Presently, the primary method for diagnosing childhood obesity relies on body mass index (BMI), yet this approach has inherent limitations. Leptin, a satiety hormone produced by adipocytes, holds promise as a superior tool for predicting both childhood and subsequent adulthood obesity. In this review, we elucidate the tools employed for assessing obesity in children, delve into the biological functions of leptin, and examine the factors governing its expression. Additionally, we discuss maternal and infantile leptin levels as predictors of childhood obesity. By exploring the relationship between leptin levels and weight loss, we present leptin as a potential indicator of the effectiveness of obesity interventions.

Keywords: BMI; adipokines; metabolic disease; obesity; weight loss; weight regain.

Publication types

  • Review

MeSH terms

  • Biomarkers* / blood
  • Body Mass Index
  • Child
  • Humans
  • Leptin* / blood
  • Pediatric Obesity* / blood
  • Pediatric Obesity* / therapy
  • Weight Loss*
  • Weight Reduction Programs / methods

Substances

  • Biomarkers
  • Leptin
  • LEP protein, human

Grants and funding